Skip to main content
SpringerLink
Log in
Discover

Collections and calls for papers

Filter by:

Accelerating Multiple Myeloma System Biology Research

Multiple myeloma (MM) is a haematological malignancy characterized by clonal proliferation of plasma cells in the bone marrow microenvironment. Despite improved survival, MM is still incurable. The interacti...
Submission status
Open
Submission deadline
09 November 2024

Advanced in Therapy Targeting Cancer and Cancer Stem Cells

This Collection is dedicated to exploring the intricate landscape of cancer, with a special emphasis on cancer stem cells, reactive oxygen species (ROS), antioxidants, and the crucial roles of endoplasmic re...
Submission status
Open
Submission deadline
30 November 2024

Advancements in Bioactive Compound-Derived Anticancer Agents

The Collection "Advancements in Bioactive Compound-Derived Anticancer Agents" aims to elucidate the evolving landscape of cancer therapeutics by exploring the potential of bioactive compounds as effective an...
Submission status
Open
Submission deadline
25 August 2024

Advances in Immunity and Immunotherapy for Blood Cancers

This Collection on "Advances in Immunity and Immunotherapy for Blood Cancers" aims to provide a comprehensive overview of the latest breakthroughs and novel approaches in the field of immunotherapy specifica...
Submission status
Open
Submission deadline
27 May 2024

Advances in Lymphoma Discovery and Treatment

Lymphomas are a group of haematological malignancies that are amongst the top ten cancers worldwide. Broadly, they may be divided into Hodgkin lymphomas and non-Hodgkin lymphomas of B-cell or T/NK-cell immun...
Submission status
Open
Submission deadline
30 June 2024

Big Data in Advancing Cancer Research

Cancer continues to pose a significant threat to human life and health, remaining a highly aggressive and deadly disease. It is a leading cause of death worldwide and presents a critical medical challenge fo...
Submission status
Open
Submission deadline
25 August 2024

Bioenergetics in Tumor Biology

The ability of cancer cells to adjust their metabolism in response to environmental changes is a well-recognized hallmark of cancer. Cancer cells have been shown to be able to use not only glucose, but also ...
Submission status
Open
Submission deadline
15 August 2024

Decoding Cancer Signalling Crosstalk Complexity

Cancer is a complex disease with disrupted signalling pathways and crosstalk, which contribute to its heterogeneity and treatment response. Traditional methods face challenges in understanding these molecula...
Submission status
Open
Submission deadline
13 July 2024

Defining the Stem Cell Phenotype in Solid Cancers

Stem cells in solid tumors have been identified almost two decades ago using a growing host of surface markers and their combinations. The community describes these cells with features of epithelial-mesenchy...
Submission status
Open
Submission deadline
01 June 2024

Epigenetic Regulation in Cancer Treatment and Drug Resistance

Epigenetic changes have been associated with tumorigenesis, progression and drug resistance. Epigenetic changes include DNA methylation, noncoding RNAs changes, genomic imprinting and histone modification. H...
Submission status
Open
Submission deadline
31 May 2024

Explorations of Environmental Exposures in Carcinogenicity

It is estimated that 80% to 90% of cancer cases can be linked to environmental factors, including lifestyle practices such as smoking and diet, as well as exposure to environmental carcinogens through contam...
Submission status
Open
Submission deadline
05 September 2024

Functional Kinome Profiling in Cancer Research

Protein kinases play a crucial role in nearly all cellular processes, both in normal cells and in tumor cells. In cancer, deregulation of protein kinases is a frequent observation and many kinases have been ...
Submission status
Open
Submission deadline
12 October 2024

Gastrointestinal Cancer Biology: Targets and Therapies

The scope of this Collection is to explore the complex biology, pathogenesis, and therapies for gastrointestinal (GI) cancers, known for their complex and aggressive nature, underscoring the necessity for in...
Submission status
Open
Submission deadline
31 October 2024

Generative AI in Breast Cancer Diagnosis and Treatment

This Collection aims to explore the burgeoning role of artificial intelligence (AI), specifically generative models, in revolutionizing the approach to diagnosing and treating breast cancer. This compilation...
Submission status
Open
Submission deadline
09 November 2024

Machine Learning for Precision Neuro-Oncology Imaging

Progress in high throughput analysis of medical images and computer vision algorithms over the past decade has opened the door for application of machine learning to further the diagnosis, prognostication, t...
Submission status
Open
Submission deadline
01 September 2024

New Horizons in Oncologic Imaging

The adoption of a multidisciplinary approach to cancer patient care has changed the landscape of oncologic practice. Using this model, oncologists, radiologists, pathologists, and others work closely toward ...
Submission status
Open
Submission deadline
25 August 2024

Peptidergic Systems and Cancer Development

Peptidergic systems are involved in cancer progression since peptides favor tumor development and also exert an anticancer action. Many peptides, through the overexpression of peptide receptors in cancer cel...
Submission status
Open
Submission deadline
30 June 2024

Recent Advances in Breast Invasive Carcinoma Research and Treatment

Invasive breast cancer is a major challenge in the field of oncology and requires continuous research and innovative treatment approaches. Understanding the genetic and molecular landscape of invasive breast...
Submission status
Open
Submission deadline
15 August 2024

Recent Advances in Cancer Genomics and Precision Medicine

Cancer genomics is an evolving field driven by advances in laboratory and computational technologies, enabling a detailed examination of the molecular and cellular aspects of cancer. This field goes beyond D...
Submission status
Open
Submission deadline
01 September 2024

Recent Advances in Diagnosis and Treatment of Rare Pediatric Tumors

Rare pediatric tumors account for approximately 10% of all childhood cancers. The diagnosis of rare tumors is challenging for pathologists owing to the diversity of tumor types and histological overlap among...
Submission status
Open
Submission deadline
31 October 2024

Recent Progress on Head and Neck Cancer Metastasis

Dear Colleagues, Head and neck cancers rank as the sixth most prevalent malignancy globally. Despite the advancements in available treatment options, the mortality rates for individuals with head and neck ca...
Submission status
Open
Submission deadline
13 July 2024

Recent Progress on Hormonal Receptor Positive Breast Cancer

Breast cancer is a complex and heterogeneous disease, with hormonal receptor positive breast cancer being one of the most common subtypes. Recent advancements in understanding the molecular mechanisms and th...
Submission status
Open
Submission deadline
09 November 2024

Role of Glycolipids in Cancer

A majority of studies on the underlying mechanisms of carcinogenesis focus on the role of the protein factors or the genes that control their synthesis. However, non-protein factors play critical roles in va...
Submission status
Open
Submission deadline
01 June 2024

The Interplay Between Viruses and Cancer

Viruses play a complex role in cancer development, often integrating their genetic material into host cells, disrupting normal cellular functions. Human papillomavirus (HPV) is a prime example, causing cervi...
Submission status
Open
Submission deadline
30 November 2024

The Tumor Microenvironment

A malignant tumor is a complex mass of tissue comprised of not just the cancer cells, but also a heterogeneous group of infiltrating and resident host cells, and their secreted factors forming the extracellu...
Submission status
Open
Submission deadline
30 June 2024

Thyroid Cancer: The Role of Nutritional and Dietary Factors

Thyroid cancer is the most frequent endocrine neoplasm worldwide and the third most common malignancy in women of all ages. In the past few decades, the global incidence of differentiated thyroid cancer has ...
Submission status
Open
Submission deadline
31 October 2024

Search

Navigation